Evaxion A/S American Depositary Share (EVAX)
Stock · NASDAQ · Health Care
$2.81as of 10/16/2026
Price chart
Active signals
EVAX Signal Track Record
How signals performed across all stocks →What EVAX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 24 | -7.6% | 25% | June 18, 2026 |
| Bollinger Band Breakout | 20 | -6.7% | 40% | August 14, 2026 |
| Volume Spike | 19 | -8.5% | 42% | August 19, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -9.2% | 17% | May 8, 2026 |
| Any 20-session window (baseline) | -6.5% | 38% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EVAX
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 46
- Website
- evaxion.ai/
Fundamentals
- 1-day range
- $2.79$2.9
- Market cap
- $24.98M
- P/E (trailing)
- —
- P/E (forward)
- -186.67
- EPS (trailing)
- $-0.02
- Dividend yield
- —
- Beta
- 0.57
- Avg. volume
- 203.3K
Forecasts
4 analyst ratings
Evaxion A/S American Depositary Share Competitors
Chosen by industry and closest market cap.
- EVAXEvaxion A/S American Depositary Share$2.83▲ 1.07%Market cap $24.98MP/E —$2.72$12.15
- GRMLGreenland Mines Ltd. Common Stock$6▼ 13.79%Market cap $22.19MP/E —$2.82$27.48
- CVMCel-Sci Corporation Common Stock$1.79▲ 2.87%Market cap $28.14MP/E —$0.89$10.24
- QNCXQuince Therapeutics Inc. Common Stock$32.03▼ 3.61%Market cap $30.04MP/E —$15.1$910
- PLURPluri Inc. Common Stock$0.93▼ 1.06%Market cap $19.53MP/E —$0.9$4.87
- JSPRJasper Therapeutics Inc. Common Stock$0.48▼ 9.77%Market cap $18.10MP/E —$0.3151$2.69
- ESLAEstrella Immunopharma Inc. Common Stock$0.43▼ 19.63%Market cap $32.10MP/E —$0.295$3.15
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EVAX Evaxion A/S American Depositary Share | $24.98M | — | $2.83 | ▲ 1.07% | $2.72$12.15 |
| GRML Greenland Mines Ltd. Common Stock | $22.19M | — | $6 | ▼ 13.79% | $2.82$27.48 |
| CVM Cel-Sci Corporation Common Stock | $28.14M | — | $1.79 | ▲ 2.87% | $0.89$10.24 |
| QNCX Quince Therapeutics Inc. Common Stock | $30.04M | — | $32.03 | ▼ 3.61% | $15.1$910 |
| PLUR Pluri Inc. Common Stock | $19.53M | — | $0.93 | ▼ 1.06% | $0.9$4.87 |
| JSPR Jasper Therapeutics Inc. Common Stock | $18.10M | — | $0.48 | ▼ 9.77% | $0.3151$2.69 |
| ESLA Estrella Immunopharma Inc. Common Stock | $32.10M | — | $0.43 | ▼ 19.63% | $0.295$3.15 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday TradingYahoo · 10/6/2026
- Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual MeetingYahoo · 10/2/2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for WeekYahoo · 9/25/2026
- European Equities Traded in the US as American Depositary Receipts Fall in Wednesday TradingYahoo · 9/23/2026
- European Equities Traded in the US as American Depositary Receipts Decline in Tuesday TradingYahoo · 9/22/2026
- European Equities Traded in the US as American Depositary Receipts Drop in Friday TradingYahoo · 9/18/2026
- European Equities Traded in US as ADRs Rise in Wednesday TradingYahoo · 9/16/2026
- Evaxion applies its AI-Immunology™ platform in autoimmune diseasesYahoo · 9/14/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 328.6K
- Total value held
- $1.22M
- Institutional holders
- 16
- Unknown74.7K
- Unknown45.7K
- Unknown39.2K
- Unknown30.0K
- Unknown22.1K
- Unknown21.7K
- Unknown19.7K
- Unknown18.4K
- Unknown17.8K
- Unknown13.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
EVAX ADRs Edge Higher Friday, End Week Lower
Evaxion ADRs saw a slight increase in Friday trading but finished the week with a net decline. This mixed performance reflects the broader movement of European equities listed in the US. The stock remains well below its 52-week high, indicating continued volatility for investors tracking this biotech firm.
EVAX ADRs Edge Higher Friday, End Week Lower. Evaxion ADRs saw a slight increase in Friday trading but finished the week with a net decline. This mixed performance reflects the broader movement of European equities listed in the US. The stock remains well below its 52-week high, indicating continued volatility for investors tracking this biotech firm.